IV Dextrose for Adult Hypoglycemia
For an adult with hypoglycemia who cannot swallow, administer 10-20 grams of IV dextrose immediately, preferably using 10% dextrose in 5-gram aliquots titrated to symptom resolution rather than a single bolus of 50% dextrose.
Immediate Treatment Protocol
When faced with an unconscious or unable-to-swallow adult with hypoglycemia (blood glucose <70 mg/dL or <3.9 mmol/L), IV glucose must be administered immediately 1. The 2024 AHA/Red Cross guidelines emphasize that for people with hypoglycemia who are unable to swallow, intravenous dextrose can be lifesaving 2.
Dosing Strategy
Initial dose: 10-20 grams of dextrose 3, 4
Preferred approach - Titrated 10% dextrose:
- Administer 5-gram aliquots (50 mL of 10% dextrose) IV over 1 minute
- Repeat every 1-2 minutes until symptoms resolve or Glasgow Coma Scale reaches 15
- Maximum total dose: 25 grams 5
Alternative - 50% dextrose:
- 20-50 mL (10-25 grams) of 50% dextrose IV 4
- FDA-labeled indication specifically for insulin hypoglycemia 4
Why 10% Dextrose is Preferred
The evidence strongly favors titrated 10% dextrose over traditional 50% dextrose boluses. Multiple studies demonstrate:
Equivalent efficacy: Both concentrations achieve similar time to Glasgow Coma Scale of 15 (median 6-8 minutes) 6, 7
Lower total dose required: Patients receiving 10% dextrose require significantly less total dextrose (median 10g vs 25g with 50% dextrose) 7
Better post-treatment glucose control: 10% dextrose results in lower post-treatment blood glucose levels (6.2 mmol/L vs 9.4 mmol/L with 50% dextrose, p=0.003) 7, avoiding rebound hyperglycemia which may have neurotoxic effects 5
Fewer adverse events: Zero adverse events reported with 10% dextrose versus documented complications with 50% dextrose including extravasation injury, direct toxic effects of hypertonic solution, and cardiac arrest with rapid administration 5, 8, 9
Lower repeat dosing needs in some studies: Though 18-23% of patients require additional doses with 10% dextrose 9, 10, this allows for more precise titration to avoid overcorrection
Administration Details
Rate of infusion: Administer slowly at 2-3 mL/min for concentrated solutions 11. The maximum rate at which dextrose can be infused without producing glycosuria is 0.5 g/kg/hour 4.
Monitoring: Check blood glucose before administering (though do not delay treatment for results in emergencies) 4. Recheck glucose every 1-2 hours during treatment 5.
Vascular access: Peripheral IV is acceptable for 10% dextrose. For 50% dextrose, use caution with peripheral access due to risk of extravasation injury and vein irritation 11, 4.
Post-Treatment Management
Immediate follow-up: After initial glucose correction, provide oral carbohydrates when the patient regains consciousness and can safely swallow 1
Continued monitoring: The glycemic response to IV glucose is transient, typically less than 2 hours 3. Provide a substantial snack or meal shortly after plasma glucose is raised 3.
Watch for recurrence: Hypoglycemia may recur depending on etiology. Sulfonylurea overdose can cause prolonged hypoglycemia requiring extended monitoring and possible continuous glucose infusion 3.
Special Considerations
Adrenal crisis: If hypoglycemia occurs in context of suspected adrenal insufficiency, administer hydrocortisone 100 mg IV immediately along with dextrose 0.5-1 g/kg 12
Pediatric dosing: Children require 0.5-1 g/kg of dextrose (2-4 mL/kg of 25% dextrose, maximum single dose 25g) 11
Avoid overcorrection: The traditional approach of administering 25g of 50% dextrose often results in excessive post-treatment hyperglycemia (median 169 mg/dL) 5. Titrated dosing with 10% dextrose achieves normoglycemia (median 112 mg/dL) more reliably 5.
Common Pitfalls
Do not underdose in emergencies: While titration is preferred, do not withhold adequate glucose in severe hypoglycemia. Untreated hypoglycemia causes seizures, status epilepticus, permanent brain injury, and death 2.
Avoid rapid bolus of 50% dextrose: Rapid administration has been associated with cardiac arrest and hyperkalemia 5. If using 50% dextrose, administer slowly.
Do not rely on glucagon in hospital settings: Glucagon (1 mg IM/SC) is slower (140 minutes to peak effect vs 10 minutes for IV dextrose), causes nausea/vomiting, and produces excessive hyperglycemia 5, 3. IV dextrose is always preferred when venous access is available.
Monitor for delayed hypoglycemia: Particularly in patients with impaired renal clearance or those who received insulin, hypoglycemia may persist or recur up to 2 hours post-treatment 13.